Zacks.com on MSN14h
AMGN's Q4 Earnings Beat, Obesity Candidate Under FDA Clinical HoldAmgen AMGN reported fourth-quarter 2024 adjusted earnings of $5.31 per share, which beat the Zacks Consensus Estimate of ...
Harvey Jones called on artificial intelligence to help him decide where to invest this year's Stocks and Shares ISA allowance ...
Earnings per share rose 24% to $3.41, compared to Wall Street's consensus estimate of $2.96, according to FactSet. Revenue for the quarter reached $11.67 billion, well above expectations of $10.91 ...
Google's balance sheet is impressive, with negative long-term debt, $110 billion in cash, and a forward dividend yield of ...
Learn more about whether Catalyst Pharmaceuticals, Inc. or Ionis Pharmaceuticals, Inc. is a better investment based on AAII's ...
Eli Lilly investors and analysts said they want to hear details from the company on how exactly it plans to grow U.S. sales ...
Quantum computing is shaping up to be the next big investing revolution, and for a very good reason. With the power to solve ...
business on MSN17h
USA’s aid-freeze poses food security threat to 60% of SSA populationBy Ernest Bako WUBONTO The withdrawal of agricultural support programmes threatens to reverse years of progress in food ...
The Bank of England is expected to enact a 25 basis point rate cut on Thursday, but policymakers face the unenviable balancing act of weighing up a stalling economy with inflation pressure. The ...
FTSE Climbs on rate cut hopes amid inflation heat; GSK Soars 7.6%. US trade gap widens.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback